D-Aspartic acid dibenzyl ester-p-toluenesulfonate, 98.0%, 25g

2-Fluoro-5-nitrophenylisothiocyanate, 97.0%, 250mg

3,3'-(Piperazine-1,4-diyl)dipropanoic acid, 98%, 1g

N4-Ethylpyridine-3,4-diamine, 95%, 100mg

N-(5-Aminopentyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 99.40%, 1g

5-(4-CHLOROPHENYL)-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 100mg

(4-Aminopiperidin-1-yl)[3-(trifluoromethyl)phenyl]methanone hydrochloride, 1g

N-(5-Oxo-5,6,7,8-tetrahydronaphthalen-2-yl)acetamide, 95.0%, 250mg

Cyclohexane [for HPLC Solvent]>99.5%(GC)500mL

(R)-2-((tert-Butoxycarbonyl)amino)-3-(2,6-dichlorophenyl)propanoic acid, 95%, 100mg

2-(6-(2-Hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl)-1-phenylethanone hydrochloride, 95.0%, 500mg

Tridecyl benzoate, 95%, 250mg

(R)-Cyclopropyl(phenyl)methanamine hydrochloride, 95.0%, 250mg